In the carcinomas, the percentages of the M, L and P isoforms of PFK-1 were 22, 16 and 62% in stage I, 18, 14 and 68% in stage II, and 17, 11 and 72% in stage III, respectively (Fig. 5A). The gene discussed is PFKM; the disease is carcinoma.